0001628280-23-020826.txt : 20230605 0001628280-23-020826.hdr.sgml : 20230605 20230605150715 ACCESSION NUMBER: 0001628280-23-020826 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230601 FILED AS OF DATE: 20230605 DATE AS OF CHANGE: 20230605 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: OBUS NELSON CENTRAL INDEX KEY: 0001017043 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-27446 FILM NUMBER: 23992123 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: LIFECORE BIOMEDICAL, INC. \DE\ CENTRAL INDEX KEY: 0001005286 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943025618 STATE OF INCORPORATION: DE FISCAL YEAR END: 0528 BUSINESS ADDRESS: STREET 1: 3515 LYMAN BOULEVARD CITY: CHASKA STATE: MN ZIP: 55318 BUSINESS PHONE: 9523684300 MAIL ADDRESS: STREET 1: 3515 LYMAN BOULEVARD CITY: CHASKA STATE: MN ZIP: 55318 FORMER COMPANY: FORMER CONFORMED NAME: LANDEC CORP \CA\ DATE OF NAME CHANGE: 19951222 4 1 wk-form4_1685992025.xml FORM 4 X0407 4 2023-06-01 0 0001005286 LIFECORE BIOMEDICAL, INC. \DE\ LFCR 0001017043 OBUS NELSON C/O LIFECORE BIOMEDICAL, INC. 3515 LYMAN BLVD. CHASKA MN 55318 1 0 0 0 0 Common Stock 2023-06-01 4 A 0 18182 A 79133 D The restricted stock units convert into common stock of Lifecore Biomedical, Inc. on a 1 for 1 basis. Restricted Stock Units will vest and be settled on the earlier of the 1st anniversary of the grant date or the date of the 2024 Annual Meeting of Stockholders (provided such date is no less than 50 weeks from Grant Date). /s/ Aaron Perlitsh, Attorney-In-Fact for Nelson Obus 2023-06-01